191 Folgen

  1. Vitreous Opacities: Hearing from Anterior and Posterior Segment Surgeons

    Vom: 1.10.2021
  2. New Retina Radio Journal Club: Exudative AMD in FILLY and GATHER1 Results

    Vom: 17.9.2021
  3. The Art of Drug Choice: International Panel in Wet AMD: Safety Data

    Vom: 10.9.2021
  4. Vitreous Opacities: Innovations and the Decision to Operate

    Vom: 3.9.2021
  5. The Art of Drug Choice: International Panel in Wet AMD: The Pipeline

    Vom: 1.9.2021
  6. International Perspectives: DME

    Vom: 27.8.2021
  7. The Art of Drug Choice: International Panel in Wet AMD: Phase 3 and Real-World Data to Watch

    Vom: 20.8.2021
  8. New Retina Radio Journal Club: Data in the Wake of COVID-19

    Vom: 13.8.2021
  9. The Art of Drug Choice: International Panel in Wet AMD: When and Why Switching Therapy Makes Sense

    Vom: 6.8.2021
  10. Surgical options for treating AMD: Clinical Implications and Impact

    Vom: 29.7.2021
  11. Advances in Gene Therapy for Wet AMD

    Vom: 26.7.2021
  12. New Retina Radio Journal Club: Masking in Retina: Keeping Patients Safe from Bacterial Exposure

    Vom: 16.7.2021
  13. Reconsidering treatment endpoints in real-world clinical practice: is achieving a favorable retreatment interval a goal of therapy?

    Vom: 9.7.2021
  14. New Retina Radio Journal Club: Autologous Retina Transplant for Macular Holes

    Vom: 25.6.2021
  15. Real-world impact of patients lost to follow-up: factors that drive nonadherence and strategies for encouraging better follow-up from patients

    Vom: 11.6.2021
  16. ARVO 2021 Coverage: NGM621 and COOG2

    Vom: 4.6.2021
  17. ARVO 2021: GATHER1 Study and CME After RRD Surgery

    Vom: 28.5.2021
  18. ARVO 2021 Coverage: TENAYA/LUCERNE Results—and Is Fluid OK in Wet AMD?

    Vom: 21.5.2021
  19. New Retina Radio Journal Club: Protocol W: How Might the Data Change Practice?

    Vom: 14.5.2021
  20. New Retina Radio Journal Club: PRO Study Group Papers: Part 2

    Vom: 15.4.2021

7 / 10

New Retina Radio is a place to hear stories about retina that are told nowhere else.

Visit the podcast's native language site